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Interhospital Transfers Among Medicare Beneficiaries
Admitted for Acute Myocardial Infarction at
Nonrevascularization Hospitals
Theodore J. Iwashyna, MD, PhD; Jeremy M. Kahn, MD, MS;
Rodney A. Hayward, MD; Brahmajee K. Nallamothu, MD, MPH
Background—Patients with acute myocardial infarction (AMI) who are admitted to hospitals without coronary
revascularization are frequently transferred to hospitals with this capability, yet we know little about the basis for how
such revascularization hospitals are selected.
Methods and Results—We examined interhospital transfer patterns in 71 336 AMI patients admitted to hospitals without
revascularization capabilities in the 2006 Medicare claims using network analysis and regression models. A total of
31 607 (44.3%) AMI patients were transferred from 1684 nonrevascularization hospitals to 1104 revascularization
hospitals. Median time to transfer was 2 days. Median transfer distance was 26.7 miles, with 96.1% within 100 miles.
In 45.8% of cases, patients bypassed a closer hospital to go to a farther hospital that had a better 30-day risk standardized
mortality rates. However, in 36.8% of cases, another revascularization hospital with lower 30-day risk-standardized
mortality was actually closer to the original admitting nonrevascularization hospital than the observed transfer
destination. Adjusted regression models demonstrated that shorter transfer distances were more common than transfers
to the hospitals with lowest 30-day mortality rates. Simulations suggest that an optimized system that prioritized the
transfer of AMI patients to a nearby hospital with the lowest 30-day mortality rate might produce clinically meaningful
reductions in mortality.
Conclusions—More than 40% of AMI patients admitted to nonrevascularization hospitals are transferred to revascular-
ization hospitals. Many patients are not directed to nearby hospitals with the lowest 30-day risk-standardized mortality,
and this may represent an opportunity for improvement. (Circ Cardiovasc Qual Outcomes. 2010;3:468-475.)
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Most acute-care hospitals in the United States are unableto provide coronary revascularization to patients with
acute myocardial infarction (AMI).1 Many AMI patients who
are admitted to nonrevascularization hospitals are therefore
transferred to revascularization hospitals during the same
admission.2 Yet, we know little of the basis for how revas-
cularization hospitals are selected during this process. In
particular, it is unclear the extent to which AMI patients are
transferred preferentially toward “higher-quality” revascular-
ization hospitals and the role that geographic distances play in
such decisions. If transfers between hospitals fail to concen-
trate AMI patients at the best-performing hospitals within a
region, opportunities would exist for improving care in this
high-risk group.
Editorial see p 441
As evidence continues to support early cardiac catheteriza-
tion and revascularization in both ST-segment–elevation
MI3,4 and high-risk non–ST-segment– elevation MI pa-
tients,5,6 it is increasingly important to understand the ways in
which transfers to revascularization hospitals occur in the real
world. Although who is transferred has been examined in the
past, there has been no previous work examining where
patients are transferred.2 Because outcomes across all revas-
cularization hospitals are not uniform,7 examining the orga-
nizational structure of transfers may provide an empirical
basis to assess interventions to optimize the use of transfer in
AMI.
Accordingly, we used network analysis to better under-
stand patterns of interhospital transfer among elderly Medi-
care beneficiaries with AMI who were initially admitted to
nonrevascularization hospitals in the United States. Our
analyses set out to examine (1) the proportion of AMI
patients admitted to hospitals without revascularization capa-
bilities transferred to revascularization hospitals, (2) the
frequency with which patients were transferred to a nearby
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hospital with the lowest 30-day risk-standardized mortality
rate (RSMR) for AMI, and (3) the relationship between a
hospital’s likelihood as a transfer destination and its 30-day
risk-standardized mortality rate for AMI after accounting for
geographic distances traveled.
WHAT IS KNOWN
" Patients with acute myocardial infarction are fre-
quently admitted to hospitals that lack the capacity
for coronary revascularization, but little is known
about the patterns of transfer.
WHAT THE STUDY ADDS
" We examined nationwide Medicare data from 2006
and found that 44% of AMI patients admitted to
nonrevascularization hospitals were transferred to a
revascularization hospital.
" We found evidence of inefficiencies in the transfer
system. For example, although patients were gener-
ally transferred to hospitals that had better 30-day
risk-standardized mortality, for 36.8% of transfers
another revascularization hospital with lower 30-day
risk-standardized mortality was actually closer than
the observed transfer destination.
" Our findings suggest that improving decision-
making on transfers has the potential to substantially
improve patient outcomes; focusing on where to
transfer a patient may complement current efforts to
optimize which patients with acute myocardial in-
farction should be transferred and when.
Methods
Data Sources and Study Population
In this retrospective cohort analysis, we analyzed all fee-for-service
Medicare beneficiaries in the 2006 Medicare Provider Analysis and
Review (MedPAR) files admitted with a primary diagnosis of AMI,
as defined by an International Classification of Diseases, 9th
Revision–Clinical Modification (ICD-9-CM) diagnostic code of
410.xx (excluding 410.x2). We excluded cases with a length of stay
less than or equal to 1 day—unless that patient died, left against
medical advice, or was transferred to another hospital—because
such a short length of stay was likely to represent “rule-out”
admissions and not true AMI.8
We empirically defined revascularization hospitals, as have others,
as those that performed at least 5 coronary bypass grafting and
percutaneous coronary intervention (PCI) procedures during the
year; all others were considered nonrevascularization hospitals.9,10
For this analysis, we included only patients initially admitted to
nonrevascularization hospitals with at least 10 AMI admissions
during the calendar year to allow more reliable estimates of our
outcomes of interest. We specifically excluded patients from hospi-
tals that performed PCI in Medicare patients but did not perform
coronary bypass grafting because such facilities receive very few
transfers from nonrevascularization hospitals and have distinct ra-
tionales for transferring out patients (eg, emergent coronary bypass
grafting after PCI).
We obtained 30-day RSMRs and volume for AMI from each
revascularization hospital using publicly-available data from 2006
on the Hospital Compare website.11,12 The approach for calculating
these rates and their validation (as compared with clinical chart
abstraction) has been described elsewhere.13,14 Briefly, the rates are
calculated from extensive Medicare inpatient and outpatient claims
data using hierarchical regression models. Of relevance for this
analysis, the approach used by Hospital Compare assigns AMI
patients to the first hospital where they received care when calcu-
lating these rates, so as not to bias facilities accepting patients in
transfer.15 To ensure that our results were not susceptible to
year-to-year fluctuations in 30-day risk-standardized mortality rates
across hospitals, we also examined the use of rates from a 3-year
period between July 2005 and June 2008 during sensitivity analysis.
We defined interhospital transfers as temporally adjacent hospi-
talizations in the same patient at 2 different facilities; the discharge
day for the nonrevascularization hospital had to be the same or 1 day
less than the admitting date of the revascularization hospital.16,17 For
each transfer, straight-line distances between the hospitals involved
were calculated.18 Additional data on geographic location and
academic affiliation were obtained from the 2005 American Hospital
Association Annual Survey.19 For subgroup analyses, we defined
hospitals as being an urban or rural facility using metropolitan
statistical areas.
We limited our analyses to AMI patients at hospitals in the 50
states and the District of Columbia. We also excluded those patients
treated at nonrevascularization hospitals with incomplete data on
facility characteristics (n!18) and at revascularization hospitals with
insufficient geographical information (n!8).
Statistical Analysis
We graphed the nationwide interhospital network of transfers for
AMI patients between nonrevascularization and revascularization
hospitals in the United States during 2006 using ArcGIS software. In
the network representation, hospitals are nodes, and the transfer of a
patient from a nonrevascularization hospital to a revascularization
hospital forms an edge.
To determine the relative importance of 30-day risk-standardized
mortality rates and geographical proximity for a hospital, we used
the McFadden discrete choice framework with a logistic regression
implementation.20,21 This model quantifies tradeoffs that are made
between several competing alternatives, each of which has several
measurable characteristics of value. In a general sense, it quantita-
tively asks the question: What characteristics of hospital A made it
more likely to be chosen as a transfer destination than other nearby
hospitals? For each patient, we compared the 30-day risk-
standardized mortality of and distance to the revascularization
hospital that was the final transfer destination with the outcomes of
and distance to other revascularization hospitals that were competing
alternatives for that transfer. Both distance and RSMR were contin-
uous variables. This approach only compares characteristics of
competing alternatives; as such, it takes into account the number of
alternatives available from any given nonrevascularization hospital.
We separately defined this set of competing alternatives to include
all other revascularization hospitals within 25 and 100 miles of the
nonrevascularization hospitals, as both are plausible distances over
which transfers might be considered.
During sensitivity analyses, we replicated this last analysis in
several important subgroups. First, we considered only patients with
a primary diagnosis of AMI at both the nonrevascularization and
revascularization hospitals. Second, we replicated the analysis sep-
arately for nonrevascularization hospitals located in urban and rural
areas. Third, we evaluated several different radii within 25 miles and
100 miles of the nonrevascularization hospital to define our set of
alternative revascularization hospitals. Further, we also controlled
for the designation as better or worse than the national average in
Hospital Compare, as well as hospital AMI volume and teaching
status. Finally, we also evaluated the impact of using distance
traveled from the patient’s home (based on the centroid of his or her
ZIP code) to the transfer destination to define the set of alternative
revascularization hospitals.
We assessed the network’s overall tendency to favor transfers to
revascularization hospitals with lower 30-day risk-standardized mor-
tality for AMI. To do so, we tested for a bivariate association
between outcomes at a revascularization hospital and the number of
nonrevascularization hospitals sending patients to that facility, after
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dividing hospitals into quintiles based on the number of sending
hospitals and using the Cuzick Wilcoxon-type nonparametric test for
trend.22 Using negative binomial regression, we asked whether
revascularization hospitals with lower RSMR tended to receive more
transfers, after adjusting for academic affiliation, urban/rural loca-
tion, and region of the country defined by US Census division.23
These analyses were conducted at the hospital level for all revascu-
larization hospitals. For the negative binomial regression, we con-
ducted and report parallel analyses with 2 dependent variables: the
number of hospitals from which patients are transferred and the
number of patients transferred in. This form of regression was used
because the dependent variables were counts, as in Poisson regres-
sion; however, negative binomial regression allows for overdisper-
sion in the counts.
To estimate the potential population impact of an optimized
transfer system, we performed a Monte Carlo simulation in which
each patient was transferred to the hospital with the lowest published
RSMR within a given radius. The aggregate potential reduction in
mortality was calculated as the sum, across all patients, of the
difference between the RSMRs for the observed transfer destination
and that of an optimized transfer destination. To incorporate the
uncertainty in the actual RSMRs, we repeated each simulation after
sampling the RSMR for both the observed and optimized destination
from a probability distribution based on its 95% confidence intervals
(CI). The differences in sampled RSMRs were then summed across
all patients, and compared with the expected mortality (based on a
mean 30-day risk-standardized mortality rate among all revascular-
ization hospitals in the sample of 0.162, applied to the same
population). The simulations were repeated 1000 times and the
resultant numeric 95% CIs were reported. (A worked example with
greater detail and sensitivity analyses is available from the authors on
request.) This analysis assumes that the average mortality risk of
transferred patients was the same as patients who were directly
admitted; that no transfers were refused or provided lower-quality
care due to capacity constraints24; that transfers were accomplished
with the high level of safety currently observed25,26; and that
revascularization hospitals provided the same outcomes of care to
transferred patients as to directly admitted patients.
All analyses were conducted in Stata 10.27 All regression standard
errors were adjusted for potential clustering of AMI patients within
a nonrevascularization hospital using Huber and White robust
standard errors.
This research was reviewed and approved by the University of
Michigan Institutional Review Board.
Results
We identified 71 336 Medicare beneficiaries admitted with
AMI at 1684 nonrevascularization hospitals in 2006. Of
these, 31 607 (44.3%) were transferred to another hospital,
with 30 875 (97.7% of transfers) directed to revascularization
hospitals. The mean age of AMI Medicare beneficiaries who
were transferred was 74.2 years; 87.6% were white, and
52.8% were men. The mean length of stay at the nonrevas-
cularization hospital before transfer was 2.5 days (standard
deviation: 3.0) with a median of 2 days. Nonrevascularization
hospitals transferred AMI patients to a median of 3 different
revascularization hospitals (interquartile range, 2 to 4), al-
though 72.2% of patients were transferred to its most com-
mon destination facility. After arrival at the revascularization
hospital, 19 513 (61.7%) patients underwent coronary revas-
cularization with 14 452 (45.7%) receiving PCI.
We constructed the 2006 nationwide interhospital network
of transfers for AMI patients between nonrevascularization
and the 1104 revascularization hospitals (Figure). The median
distance patients traveled to a revascularization hospital was
26.7 miles (interquartile range, 11.6 to 46.7 miles). Overall,
48.2% of transfers were within 25 miles and 96.1% of
transfers were within 100 miles. Transfers originating in rural
areas traveled a median of 47.3 miles (interquartile range,
32.8 to 69.2 miles), whereas those originating in urban
settings traveled a median of 13.9 miles (interquartile range,
6.6 to 25.0 miles). The median number of revascularization
hospitals within 25 and 100 miles of each nonrevasculariza-
tion hospital was 3 and 18, respectively.
When a patient is to be transferred, a potential destination
hospital’s proximity and 30-day risk-standardized mortality
rates might both be taken into consideration. In 6.0% of cases,
patients went to the nearest revascularization hospital, and
that hospital also had the best 30-day risk-standardized
mortality of all revascularization hospitals within 100 miles.
In 45.8% of cases, patients bypassed a closer hospital to go to
farther hospital that had a better 30-day risk standardized
mortality rates. However, patients also frequently bypassed
hospitals with better mortality outcomes to go to hospitals
farther away. In 36.8% of cases, another revascularization
hospital with lower 30-day risk-standardized mortality was
actually closer to the original admitting nonrevascularization
hospital than the observed transfer destination. In 27.2% of
cases, another revascularization hospital was closer and had a
30-day risk-standardized mortality rate more than 1 percent-
age point better than the observed transfer destination. As
Table 1 shows, patients were infrequently transferred to the
hospital with the lowest 30-day risk-standardized mortality
rate within any given radius.
Patients were transferred farther to go to a revasculariza-
tion hospital with improved 30-day risk-standardized mortal-
ity when such an option was available. However, there
appeared to be a trade-off between these 2 factors, and the
additional distances traveled were small on average. In rural
settings, each 1 percentage point improvement in 30-day
risk-standardized mortality rate increased a revascularization
hospital’s odds of being the destination by 19% (95% CI,
13% to 26%), whereas being 10 miles closer doubled the odds
of being chosen (odds ratio, 2.05; 95% CI, 1.94 to 2.18). In
urban settings, proximity was even more important: Although
each 1 percentage point improvement in its 30-day risk-
standardized mortality rate increased its odds of being the
destination by 16% (95% CI, 10% to 21%), being 10 miles
closer nearly quadrupled the odds of being chosen (odds ratio,
3.87; 95% CI, 3.41 to 4.38).
The high value of proximity relative to observed 30-day
risk-standardized mortality persisted when controlling for
other characteristics of the revascularization hospital that
have been associated with improved outcomes, such as total
volume of AMI patients and teaching status (Table 2). Still,
high-volume hospitals and teaching hospitals (particularly in
rural areas) were more likely to be destinations than other
equally close hospitals, showing that these factors were not
ignored. In sensitivity analyses, very similar results were
obtained when considering distance traveled from the pa-
tient’s home ZIP code rather than from the nonrevasculariza-
tion hospital initiating the transfer. Likewise, substantively
identical results were obtained when using the 30-day risk
standardized mortality rates for 2005 to 2008, or when
470 Circ Cardiovasc Qual Outcomes September 2010
 at University of Michigan--Ann Arbor on September 16, 2010 circoutcomes.ahajournals.orgDownloaded from 
controlling for a hospital’s designation as better or worse than
the national average in Hospital Compare.
Despite the apparent high value placed on proximity,
revascularization hospitals with lower 30-day mortality mea-
sures received more transfers. Revascularization hospitals
varied substantially in the number of nonrevascularization
hospitals that sent them transfers (Table 3): 147 (13.3% of
1104) received no transfers, whereas 49 (4.4%) hospitals
received transfers from 15 or more other hospitals. Revas-
cularization hospitals with lower 30-day risk-standardized
mortality rates, in general, received transfers from more
hospitals. After adjusting for academic affiliation, urban/rural
location and region of the country, a 1% lower 30-day
risk-standardized mortality rate was associated with a 6.5%
increase in the number of hospitals from which transfers were
received (P"0.001). Similarly, revascularization hospitals
with better outcomes also received more total AMI patients in
transfer.
To contextualize these results, we simulated the potential
impact of a system that optimized patient transfers exclu-
Figure. Transfers of AMI patients from
nonrevascularization hospitals. This map
shows transfers of patients from nonre-
vascularization hospitals (yellow) to re-
vascularization hospitals (green). The
thickness of the lines is proportional to
the number of transfers between the
hospitals. The diameter of the markers
for revascularization hospitals is
inversely proportional to their 30-day
risk-standardized mortality, with hospi-
tals with better outcomes having larger
diameters.
Table 1. Fraction of Transfers That Are to the Revascularization Hospital With Best Outcomes Within Different Radii Around Non-PCI




Percent of All Transfers
That Were Within Radius
Percent to
Best
Percent to Within 0.5
Percentage Points of Best*
Percent to Within 1.0
Percentage Points of Best*
100 29 654 93.8% 13.1% 15.5% 20.0%
75 28 264 89.4% 17.7% 21.1% 28.3%
50 24 029 76.0% 24.9% 30.3% 38.9%
25 14 883 47.1% 41.1% 44.1% 51.4%
*The 0.5 refers to a one-half percentage point of the best 30-day risk-adjusted mortality rate of any revascularization hospital within the given radius, and 1.0 refers
to within 1 percentage point of the best. These columns are not exclusive; all patients transferred to the best were, by definition, also transferred to a hospital within
1.0 of best.
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sively on the basis of 30-day risk-standardized mortality rates
(Table 4). In the baseline case, an optimized system that
always transferred patients to the lowest 30-day mortality
hospital within 100 miles might reduce absolute mortality 2.7
percentage points (95% CI, 2.6 to 2.7 percentage points), a
relative reduction of 16.5% at 30 days after AMI (95% CI,
16.3% to 16.8%). An optimized system that never transferred
patients farther than they were currently transferred and never
more than 100 miles might reduce absolute mortality by 0.78
percentage points (95% CI, 0.77 to 0.80 percentage points), a
relative reduction of 4.8% (95% CI, 4.7% to 5.0%) while also
reducing travel time. Table 4 shows the extent to which an
optimized transfer system might offer meaningful reductions
in 30-day AMI mortality as the maximum transfer distance is
varied.
Discussion
More than 40% of elderly Medicare beneficiaries with AMI
who are admitted at hospitals without revascularization are
ultimately transferred to revascularization hospitals during
their hospitalization. We find evidence that these patients are
preferentially transferred toward hospitals with lower 30-day
risk-standardized mortality rates, but that this pattern of
movement between facilities with different levels of services
provided may be suboptimal. For example, only a minority of
patients are transferred and of those transferred, many are
transferred to revascularization hospitals with higher mortal-
ity rates than other revascularization hospitals within similar
distances. Indeed, more than one third of patients had a
revascularization hospital that was both closer and with better
outcomes than the observed destination. This suggests that in
general, optimizing the transfer process might result in
clinically meaningful improvements in patient outcomes.
Past work has examined the characteristics of patients most
likely to be transferred; ours is the first study to examine the
system-level patterning of those transfers.16,17 For example,
an analysis of the CRUSADE initiative showed that 46.1% of
patients with non–ST elevation acute coronary syndromes
were transferred to revascularization centers from community
hospitals.28 Further, lower-risk patients appear to be prefer-
entially transferred early in their hospital course. These
findings reinforce the pattern noted in 1994 to 1995 data on
Medicare beneficiaries from the Cooperative Cardiovascular
Project within Michigan.2 Claims data lack the clinical
granularity to reexamine the appropriateness of any given
decision to transfer or not. Instead, our data raise the
Table 2. Association Between Destination Hospital Characteristics and Their Odds of Being a
Transfer Destination
Odds Ratio 95% CI Odds Ratio 95% CI
Urban hospitals
Proximity (per 10 miles closer to
nonrevascularization hospital)
3.87 3.41 4.38 3.94 3.48 4.46
30-Day risk-standardized mortality (per 1%
absolute improvement)
1.16 1.10 1.21 1.07 1.02 1.12
AMI volume (per 100 patients) 1.67 1.55 1.80
Hospital residency program (vs not) 1.10 0.88 1.37
Affiliated with medical school 1.18 0.93 1.51




Proximity (per 10 miles closer to
nonrevascularization hospital)
2.05 1.94 2.18 2.22 2.09 2.36
30-Day risk-standardized mortality (per 1%
absolute improvement)
1.19 1.13 1.26 1.05 0.99 1.11
AMI volume (per 100 patients) 2.11 1.91 2.32
Hospital residency program (vs not) 1.60 1.23 2.09
Affiliated with medical school 0.96 0.73 1.25
Member of the Council of Teaching
Hospitals
1.85 1.51 2.25
These odds ratios are from a McFadden discrete choice model, implemented with conditional logistic regression. Characteristics
of the revascularization hospital that received each transfer are compared with those of all other revascularization hospitals within
100 miles of the sending nonrevascularization hospital.
Table 3. Association Between Number of Hospitals From
Which Transfers Are Received and 30-Day Risk-Standardized













0 to 1 309 16.39 1.57
2 155 16.51 1.65
3 to 4 257 16.22 1.64
5 to 7 188 16.01 1.55
8 to 39 195 15.67 1.84
For ease of display, hospitals are divided into quintiles based on the number
of hospitals from which transfers were received. Groups are divided as evenly
as possible given the clumping of hospitals receiving few transfers. The Cuzick
Wilcoxon-type nonparametric test for trend was P"0.001 across groups.
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possibility that patients often bypass nearby revascularization
hospitals with better outcomes, once the decision to transfer
has been made. Future studies will need to evaluate how the
decision to transfer is initiated, how patients are selected, and
what processes are in place for determining the destination.
There are several potential reasons why patients may not
be transferred to nearby revascularization hospitals with the
best outcomes. First, logistical barriers as the result of bed
occupancy or physician availability may prevent a revascu-
larization hospital from accepting patients at the moment a
transfer is needed. Timeliness of revascularization is an
essential part of the care of AMI patients, and, theoretically,
better hospitals must be available when transfers are required.
Second, the choice of transfer destination may be a routine
rather than conscious decision for any particular patient.
More than 70% of transfers from nonrevascularization hos-
pitals went to a single revascularization hospital, suggesting
well-established relationships between facilities. These rela-
tionships may be driven by the presence of supplemental
insurance or by corporate relationships between hospitals that
send and receive patients; however, our evidence emphasizes
that such nonclinical issues may have clinical consequences
for patients, who may not be sent to the best available facility.
Third, publicly available information on hospital perfor-
mance in AMI patients may not have been available for a
sufficient time to patients and providers. Data from Hospital
Compare used in this analysis have only recently become
available and may not have become incorporated into these
decisions by 2006. However, the impact of public informa-
tion about the quality of healthcare providers has not been
substantial to date.29–31 Fourth, it is possible that providers
and patients considered the individual “rankings” of hospital
performance in Hospital Compare unreliable even when they
were familiar with the information. Finer grain information
that allows individuals to make reliable decisions is urgently
needed to change these population-level outcomes.
Finally, another important possibility is that patients might
highly value proximity of care relative to outcomes even if
these other challenges were resolved.32 In a recent survey of
AMI patients who had been transferred for primary PCI in the
setting of ST elevation, more than 15% of respondents
responded that they would have preferred receiving care
locally despite the potential mortality benefits associated with
transfer.33 Efforts to optimize the care of patients need to
consider strategies to minimize the psychological distress
associated with transfer while achieving the best outcomes
possible.34
Despite these multiple barriers, there is evidence that
current patterns of transfer at least partially consider hospital
performance. We observe that on average hospitals with
better outcomes received more patients from more hospitals.
More reliable and accessible information might take advan-
tage of these decentralized mechanisms, potentially if cou-
pled to incentives to optimize outcomes. Linking accountabil-
ity for transfers back to the nonrevascularization hospital
could also be helpful, a practice that is already in place
through the publicly reported data from Hospital Compare, in
which 30-day AMI mortality rates for nonrevascularization
hospitals include patients who were ultimately transferred to
a revascularization hospital. There may be a role for individ-
ual physicians and hospitals to view their own referral
practices through a quality-improvement lens, independent of
any system-level reform to improve transfers.
This empirical work has several limitations that should be
kept in mind. First, we studied transfer patterns within
Medicare and after hospital admission. Other insurers may
actively shape transfers to meet different clinical or economic
objectives. Similarly, our analyses do not address transfers
that occur between emergency departments before hospital
admission. Second, we lacked detailed clinical information to
evaluate whether the decision to transfer was “right” or
“optimal” for particular patients. Medicare claims did not
allow for us to reliably determine why more than 50% of AMI
patients were not transferred, nor to distinguish ST-segment–
elevation MI and non–ST-segment–elevation MI. For some
patients, this may be due to patient and family preference to
undergo noninvasive stress testing or advanced comorbidities
or other relative contraindications to cardiac catheterization
or revascularization. Some have even suggested that sicker
patients may be less likely to be transferred from community







Optimized Transfer Potential Reduction
in Mortality (95% CI)
Relative Absolute
100 29 654 93.8% 16.5% (16.3–16.7) 2.7% (2.6–2.7)
75 28 264 89.4% 14.4% (14.2–14.6) 2.3% (2.3–2.4)
50 24 029 76.0% 11.9% (11.7–12.1) 1.9% (1.9–2.0)
25 14 883 47.1% 9.4% (9.2–9.6) 1.5% (1.5–1.6)
No further than observed and
within 100 miles*
29 654 93.8% 4.8% (4.7–5.0) 0.78% (0.77–0.80)
The potential reductions in mortality are the summed differences between risk-standardized mortality rate of the
observed transfer destination and a system that always transferred a patient to the revascularization hospital with the
lowest 30-day risk-standardized mortality. Please see text for a discussion of the important simplifying assumptions used
to generate these estimates. 95% CIs take into account the uncertainty about actual RSMRs of observed and optimized
transfer hospitals, using 1000 Monte Carlo simulations.
*The restriction to within 100 miles is based on the assumption that longer range transfers may occur for idiosyncratic
reasons; the inclusion of such transfers might inappropriately bias the potential benefits upward.
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hospitals to academic centers.2,28 However, these issues are
beyond the scope of our work. Our primary goal was to
evaluate where patients were directed after the decision for
transfer had been made. Third, the 30-day risk-standardized
mortality for a specific hospital is a point estimate with a 95%
CI. Comparing the decision to transfer a given patient
between 2 specific hospitals is not possible from this analysis.
Instead, we focused on the patterns of transfer from a
population-level perspective, which is more critical for poli-
cymakers. We also accounted for uncertainty in estimates of
a hospital’s 30-day risk-standardized mortality in our Monte
Carlo simulations. Finally, we assumed that revascularization
hospitals perform as well for transferred patients as they do
for patients directly admitted with AMI; in theory, some
hospitals might perform disproportionately better in one or
the other population. Indeed, some decision-makers may
prefer to focus on outcomes other than mortality, such as a
risk-stratified readmission rate or other process measures; it
would be valuable if our work were replicated with other
measures. Future work explicitly measuring the care provided
to transfer patients may be of substantial benefit in guiding
policy and clinical decision-making on this important issue.
Conclusion
The transfer of patients to revascularization hospitals is a
frequent part of the care of AMI patients at nonrevascular-
ization hospitals. Although revascularization hospitals with
lower 30-day risk-standardized mortality rates receive more
of these transfers, many patients are not directed toward local
hospitals with the best outcome rates. Consequently, efforts
to systematically improve these transfer decisions, both at the
level of the health systems and individual referring physi-
cians, may represent an important opportunity to positively
affect outcomes for patients with AMI.
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